IP Library Granted Patent US 9,050,349
Granted Patent B2
US 9,050,349 · App. 13/914,510 · Granted Jun 9, 2015

Synthetic bile acid compositions and methods

Inventors: Robert M. Moriarty (Michiana Shores, IN); Nathaniel E. David (Los Angeles, CA); Nadir Ahmeduddin Mahmood (Calabasas, CA)
Assignee: KYTHERA BIOPHARMACEUTICALS, INC.
A61K31/575Y10T436/201666A61K45/06C07J9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,349
App. No.
13/914,510
Granted
Jun 9, 2015
Kind
B2
Abstract

Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.

Claims (18)

1. A syringe or syringe-loadable container comprising a composition comprising a deoxycholate salt and at least one pharmaceutically acceptable excipient and/or carrier, wherein the deoxycholate has a 14 C content of less than 1 ppt.

2. The syringe or syringe-loadable container of claim 1 , wherein said deoxycholate salt is sodium deoxycholate.

3. The syringe or syringe-loadable container of claim 2 , wherein said sodium deoxycholate is present at a concentration of about 0.5% (w/v), about 1% (w/v), about 2% (w/v), or about 5% (w/v) in said composition.

4. The syringe or syringe-loadable container of claim 1 , wherein said pharmaceutically acceptable excipient is selected from the group consisting of: water, a buffer, benzyl alcohol, and combinations thereof.

5. The syringe or syringe-loadable container of claim 1 , wherein said pharmaceutically acceptable excipients consist of a buffer and benzyl alcohol.

6. The syringe or syringe-loadable container of claim 1 , wherein the deoxycholate has a 14 C content of less than 0.9 ppt.

7. A syringe or syringe-loadable container comprising an aqueous pharmaceutical composition comprising a deoxycholate salt and at least one pharmaceutically acceptable excipient and/or carrier, wherein the deoxycholate has a 14 C content of less than 1 ppt.

8. The syringe or syringe-loadable container of claim 7 , wherein said deoxycholate salt is sodium deoxycholate.

9. The syringe or syringe-loadable container of claim 8 , wherein said sodium deoxycholate is present at a concentration of about 0.5% (w/v), about 1% (w/v), about 2% (w/v), or about 5% (w/v) in said composition.

10. The syringe or syringe-loadable container of claim 7 , wherein said pharmaceutically acceptable excipient is selected from the group consisting of: water, a buffer, benzyl alcohol, and combinations thereof.

11. The syringe or syringe-loadable container of claim 7 , wherein said pharmaceutically acceptable excipients consist of a buffer and benzyl alcohol.

12. The syringe or syringe-loadable container of claim 7 , wherein the deoxycholate has a 14 C content of less than 0.9 ppt.

13. A syringe or syringe-loadable container comprising an aqueous pharmaceutical composition comprising a deoxycholate salt, phosphatidyl choline and at least one pharmaceutically acceptable excipient and/or carrier, wherein the deoxycholate has a 14 C content of less than 1 ppt.

14. The syringe or syringe-loadable container of claim 13 , wherein said deoxycholate salt is sodium deoxycholate.

15. The syringe or syringe-loadable container of claim 14 , wherein said sodium deoxycholate is present at a concentration of about 0.5% (w/v), about 1% (w/v), about 2% (w/v), or about 5% (w/v) in said composition.

16. The syringe or syringe-loadable container of claim 13 , wherein said pharmaceutically acceptable excipient is selected from the group consisting of: water, a buffer, benzyl alcohol, and combinations thereof.

17. The syringe or syringe-loadable container of claim 13 , wherein said pharmaceutically acceptable excipients consist of a buffer and benzyl alcohol.

18. The syringe or syringe-loadable container of claim 13 , wherein the deoxycholate has a 14 C content of less than 0.9 ppt.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Oct 10, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050684/0953 →
CHANGE OF NAME Recorded Oct 7, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050649/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2013
From: MORIARTY, ROBERT M.; DAVID, NATHANIEL E.; MAHMOOD, NADIR AHMEDUDDIN
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 031247/0694 →
Continuity (6)
Continuation 13486955 · Jun 1, 2012
Continuation 12541045 · Aug 13, 2009
Continuation In Part 12035339 · Feb 21, 2008
Provisional Application 60945035 · Jun 19, 2007
Provisional Application 60956875 · Aug 20, 2007
Related Publication 20140038932A1 · Feb 6, 2014